VieCure, a Denver, CO-based provider of an intelligence platform that aims to democratize community oncology care, raised $45M in funding.
The round was led by Northpond Ventures.
The company intends to use the funds to scale commercial operations to meet the demand for its patented Halo Intelligence platform.
Led by CEO Michael Power, VieCure is a provider of intelligence platforms for community oncology care. Its Halo Intelligence platform is an AI-enabled clinical decision support and smart electronic medical record system that assists clinicians in managing a patient’s personalized treatment plan throughout cancer diagnosis, therapy, and follow-up care.
The platform includes an integrated ecosystem of tools, including an oncology information management system, AI engine, mobile patient and physician apps, a codified content library, integrated telehealth, and a modern analytics data environment. The dynamic Halo Intelligence platform connects every element essential for diagnostics and treatment centered around the patient-physician interaction, encompassing discrete patient data, physician notes, clinical records, treatment responses, radiology images, pathology-based tumor profiles, molecular features, and wearable devices.
VieCure was launched in 2016, and its community cancer center network now includes more than 100 locations. Over 18,000 patients are managed daily on the platform.
The company also announced the appointment of industry veteran Richard Daly as chairman of the board of directors.
FinSMEs
02/10/2024